The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis.
Study Design
- نوع الدراسة
- Review
- المجتمع المدروس
- Cancer patients (SLC6A14 transporter review)
- التدخل
- The Na+/Cl--Coupled, Broad-Specific, Amino Acid Transporter SLC6A14 (ATB0,+): Emerging Roles in Multiple Diseases and Therapeutic Potential for Treatment and Diagnosis. None
- المقارن
- None
- النتيجة الأولية
- None
- اتجاه التأثير
- Mixed
- خطر التحيز
- Unclear
Abstract
Amino acids are essential building blocks of all mammalian cells, and amino acid transporters play a vital role in transporting them into cells and their further distribution among the various cellular compartments. There are ~ 430 known transporters in the solute-linked carrier (SLC) gene family, divided into 52 distinct families. Eleven of these gene families contain one or more amino acid transporters. These transporters differ significantly from each other in terms of substrate specificity, ion dependence, and energetics. Given the variety of roles they fulfill in human physiology, it is not surprising that a number of diseases are associated with the malfunction of these transporters. In particular, as amino acids are critical for cell growth, survival, and proliferation, the role of amino acid transporters in cancer is gaining increasing attention in recent years. The present review primarily focuses on one particular amino acid transporter, SLC6A14 (also known as ATB0,+), with regard to its relevance to specific diseases, including cancer, and the molecular mechanisms underlying the disease-related alterations in the expression of the transporter. Furthermore, the review highlights the possible utility of this transporter in drug delivery and also its therapeutic potential for the treatment and diagnosis of cancer.
باختصار
The present review primarily focuses on one particular amino acid transporter, SLC6A14 (also known as ATB0,+), with regard to its relevance to specific diseases, including cancer, and the molecular mechanisms underlying the disease-related alterations in the expression of the transporter.
Used In Evidence Reviews
Similar Papers
The Cochrane database of systematic reviews · 2018
Enteral nutritional therapy for induction of remission in Crohn's disease.
Gut · 2010
MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.
The Cochrane database of systematic reviews · 2007
Enteral nutritional therapy for induction of remission in Crohn's disease.
Journal of pediatric gastroenterology and nutrition · 2000
Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease.
Alimentary pharmacology & therapeutics · 2003
Review article: nutrition and adult inflammatory bowel disease.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 1997